XTX Topco Ltd reduced its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 61.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,823 shares of the technology company’s stock after selling 18,903 shares during the period. XTX Topco Ltd’s holdings in Koninklijke Philips were worth $299,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in PHG. State Street Corp boosted its position in Koninklijke Philips by 1.0% during the 3rd quarter. State Street Corp now owns 82,518 shares of the technology company’s stock valued at $2,809,000 after purchasing an additional 844 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Koninklijke Philips in the third quarter valued at $54,000. JPMorgan Chase & Co. boosted its holdings in shares of Koninklijke Philips by 315.0% during the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock valued at $8,040,000 after acquiring an additional 186,520 shares during the period. GAMMA Investing LLC grew its position in shares of Koninklijke Philips by 6.3% during the fourth quarter. GAMMA Investing LLC now owns 10,963 shares of the technology company’s stock worth $278,000 after acquiring an additional 648 shares during the last quarter. Finally, Bar Harbor Wealth Management increased its holdings in shares of Koninklijke Philips by 2.1% in the 4th quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company’s stock worth $7,803,000 after acquiring an additional 6,281 shares during the period. 13.67% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on PHG. UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy”.
Koninklijke Philips Stock Up 1.0 %
PHG stock opened at $24.71 on Friday. The firm’s 50-day moving average is $25.15 and its two-hundred day moving average is $26.49. The company has a market capitalization of $23.23 billion, a price-to-earnings ratio of -29.42, a price-to-earnings-growth ratio of 0.82 and a beta of 0.81. Koninklijke Philips has a 52 week low of $19.90 and a 52 week high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59.
Koninklijke Philips (NYSE:PHG – Get Free Report) last announced its earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.01). The firm had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.
Koninklijke Philips Cuts Dividend
The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a $0.886 dividend. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Stories
- Five stocks we like better than Koninklijke Philips
- Why Invest in High-Yield Dividend Stocks?
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- How to Effectively Use the MarketBeat Ratings Screener
- Why Smart Investors Don’t Panic in Election Season
- Using the MarketBeat Dividend Tax Calculator
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.